Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Recursion Pharma

Request full access

A clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery

Salt Lake City, United StatesFounded 2013Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2021

Recursion Pharma in the Salt Lake City ecosystem

Live from Dealroom

The Recursion Pharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

32 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Central Texas Angel Network
  • Bill & Melinda Gates Foundation

Series A11 investors entered at this stage

Series B and later19 investors entered at this stage

Employees mapped 942 incl. 83 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 52 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 11 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$23M

117 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Recursion Pharma was the backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Recursion Pharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Recursion Pharma deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Recursion Pharma's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        See Recursion Pharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.